Florida’s program is the first to get official approval in an effort to reduce drug costs.

RBMA President Kit Crancer said a lack of federal policy has driven 20 states to adopt laws requiring that insurance cover the costs. 

Boston Scientific Corp. is purchasing Axonics in a move the buyer says will allow it to pursue a ripe segment of the urology market. 

Geraldine McGinty, MD, Weill Cornell Medicine, explains how practices can retain radiologists during the Great Resignation in healthcare.

Both providers and payers upped their game on price transparency in 2023.

Private equity is becoming more and more influential in many healthcare specialties, including cardiology. This has prompted increased speculation about the impact such investments may have on patient outcomes.

Congress has already adjourned for the year without taking action, but U.S. medical societies are hoping relief from significant Medicare cuts will arrive in early 2024. 

What happens when hospitals en masse stock up on supplies to withstand a health crisis of unknown duration?